$121.72
-5.09-4.01%
In chiusura: -
$119.04
-2.68-2.20%
After hour: 6:25 PM EDT
GeneDx Holdings segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di GeneDx Holdings utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
WGS | GeneDx Hldgs | $0.04 | $0.36 | — | — | $76.87M | $104.11M | — | — | 10/28/2025 | |
WGS | GeneDx Hldgs | -$0.10 | $0.10 | $0.50 | 400.00% | $70.51M | $85.23M | $102.69M | 20.49% | 07/29/2025 | |
WGS | GeneDx Hldgs | -$0.33 | $0.09 | $0.27 | 200.00% | $62.42M | $79.81M | $87.11M | 9.15% | 04/30/2025 | |
WGS | GeneDx Hldgs | -$0.69 | $0.10 | $0.60 | 500.00% | $57.42M | $82.24M | $95.64M | 16.29% | 02/18/2025 | |
WGS | GeneDx Hldgs | -$1.22 | -$0.21 | $0.04 | 119.05% | $53.30M | $64.99M | $76.87M | 18.29% | 10/29/2024 | |
WGS | GeneDx Hldgs | -$1.65 | -$0.30 | -$0.10 | 66.67% | $48.71M | $59.24M | $70.51M | 19.03% | 07/30/2024 | |
WGS | GeneDx Hldgs | -$2.44 | -$0.67 | -$0.33 | 50.75% | $43.14M | $49.46M | $62.42M | 26.21% | 04/29/2024 | |
WGS | GeneDx Hldgs | -$29.04 | -$0.75 | -$0.69 | 8.00% | $61.35M | $55.43M | $57.42M | 3.59% | 02/20/2024 | |
WGS | GeneDx Hldgs | -$6.60 | -$1.31 | -$1.22 | 6.87% | $83.23M | $52.41M | $53.30M | 1.70% | 10/30/2023 | |
WGS | GeneDx Hldgs | -$7.26 | -$1.31 | -$1.65 | -25.95% | $36.17M | $47.63M | $48.71M | 2.26% | 08/08/2023 | |
WGS | GeneDx Hldgs | -$8.91 | -$2.80 | -$2.44 | 12.86% | $53.94M | $38.01M | $43.14M | 13.49% | 05/09/2023 | |
WGS | GeneDx Hldgs | -$16.17 | -$5.28 | -$29.04 | -450.00% | $57.80M | $70.95M | $61.35M | -13.53% | 03/14/2023 | |
WGS | GeneDx Hldgs | -$14.19 | -$6.93 | -$6.60 | 4.76% | $43.18M | $71.67M | $83.23M | 16.14% | 11/14/2022 | |
WGS | GeneDx Hldgs | $0.00 | -$7.26 | -$7.26 | 0.00% | $46.87M | — | $36.17M | — | 08/15/2022 | |
WGS | GeneDx Hldgs | — | -$10.23 | -$8.91 | 12.90% | — | $52.90M | $53.94M | 1.97% | 05/12/2022 | |
WGS | GeneDx Hldgs | — | -$8.58 | -$16.17 | -88.46% | — | $49.66M | $57.80M | 16.39% | 03/14/2022 | |
WGS | GeneDx Hldgs | — | -$6.27 | -$14.19 | -126.32% | — | $42.68M | $43.18M | 1.17% | 11/15/2021 | |
WGS | GeneDx Hldgs | — | — | $0.00 | — | — | — | $46.87M | — | 08/16/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-29 | $0.50 | $0.10 | 400.0 % |
Q1 | 2025-04-30 | $0.27 | $0.09 | 200.0 % |
Q4 | 2025-02-18 | $0.60 | $0.10 | 500.0 % |
Q3 | 2024-10-29 | $0.04 | $-0.21 | 119.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-29 | $102.69M | $85.23M | 20.5 % |
Q1 | 2025-04-30 | $87.12M | $79.81M | 9.15 % |
Q4 | 2025-02-18 | $95.64M | $82.24M | 16.3 % |
Q3 | 2024-10-29 | $76.87M | $64.99M | 18.3 % |
Si prevede che GeneDx Holdings (WGS) fornisca risultati il ottobre 28, 2025. Gli ultimi risultati sono stati pubblicati il luglio 29, 2025 per il Q2.
L'EPS effettivo era $0.50, che superato la stima di $0.10.
Le entrate effettive sono state $102.7M, che superato la stima di $85.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.